Press & News

We’re pushing boundaries and making news

  1. Nov 21
    2022

    Validating Our Blood Testing Innovations

    What do we mean when we say we're a "science-first" company?

  2. Sep 20
    2022

    Babson Diagnostics Welcomes Four New Leaders to Management Team

    Key expertise added as Babson works to commercialize its reimagined blood testing ecosystem.

  3. Sep 07
    2022

    Preventative Healthcare Access for All Patients

    Better outcomes start with meeting patients where they are.

  4. Jul 26
    2022

    Babson Diagnostics and Pharmacy Podcast Network Announce Partnership That Will Take Listeners Inside Largest Retail Pharmacy Trade Show

    Media partnership announced in connection with the 2022 National Association of Chain Drug Stores' Total Store Expo.

  5. Jun 13
    2022

    Medical Claims Data Underscores Need to Improve Lab-Testing Access and Action

    Claims data underscores need to improve preventative care.

  6. Jun 07
    2022

    Why Innovation in Blood Testing Matters

    When people think about innovations that can reshape health care, why don’t they usually think about blood testing?

  7. May 11
    2022

    Babson Diagnostics, BD Expand Strategic Partnership to Advance Diagnostic Blood Collection in New Care Settings

    Expanded collaboration agreement to make less invasive blood sample collection more convenient and patient centered.

  8. Mar 21
    2022

    How Do We Fill The Data Gap In Virtual Care?

    Babson Diagnostics CEO David Stein details how can patients and providers get the most from virtual care.

  9. Mar 17
    2022

    Babson Diagnostics Recognized for Achieving Highest Standards for Laboratory Medicine

    Babson awarded accreditation by CAP for meeting the highest standards of quality and patient safety in lab practices.

  10. Jan 19
    2022

    Babson Diagnostics Grows Leadership Team with Key Executive Hires

    Healthtech firm prepares for commercial launch of disruptive blood-testing ecosystem.

  11. Jan 04
    2022

    Health Tech Needs to Rebuild Trust in the Wake of the Theranos Verdict

    Babson Diagnostics CEO David Stein shares some ideas about how we as an industry move forward from the Theranos scandal.

  12. Nov 12
    2021

    Raising Diabetes Awareness Starts with Testing

    With November being National Diabetes Month, it’s a good time to take stock of the toll this disease takes on our country.

  13. Oct 15
    2021

    Pharmacies and the Future of Health Care

    Use of COVID-19 testing and vaccination services at community pharmacies demonstrates they can play a bigger role in care delivery.

  14. Jul 27
    2021

    Babson Diagnostics Strengthens Senior Leadership Team with Two Appointments

    Babson brings in top talent from the largest and most respected retail and health care services organizations in the country.

  15. Jun 29
    2021

    Babson Diagnostics Raises $31 Million in Series B Funding to Drive Retailization of Customer-First, Convenient, and Highly Accessible Diagnostic Blood Testing

    The Series B fundraise will accelerate the commercialization of Babson’s disruptive technology that will make routine blood testing easier, more accessible, and less invasive.

  16. May 04
    2021

    Time for Innovation in Blood Testing Technology

    We live in a just-in-time world. We only need to pick up our smartphones and within moments we order a car to drive us home. Or book a reservation at a hotel or restaurant.

  17. Mar 09
    2021

    Babson Diagnostics Named Fierce MedTech "Fierce 15" Company

    Babson named one of Fierce Medtech’s elite “Fierce 15" as a promising private company in the global health care industry.

  18. Jan 25
    2021

    Babson Diagnostics First to Conduct Full Blood Panel Testing from a Finger Sample in a Retail Setting

    According to the CDC, 70% of today’s medical decisions depend on laboratory test results, and over 14 billion laboratory tests are ordered annually—but primary care clinicians indicate up to 30% of prescribed diagnostic tests are not filled by patients.

  19. Sep 24
    2020

    Babson Diagnostics Appoints Former Siemens Healthineers Executive to CEO

    Babson has appointed David Stein, Ph.D., former head of global strategy and innovation at Siemens Healthineers, to chief executive officer. Eric Olson, Babson’s founder and former CEO, will assume the roles of chairman of the board and chief operating officer.

  20. Sep 24
    2020

    Babson Diagnostics Closes $13.7 Million Series A to Democratize Diagnostic Blood Testing

    Babson announced today it closed $13.7 million in cumulative Series A funding, led by Siemens Healthineers, Prism Ventures, Genesis Merchant Capital, and Lago Consulting Group.

  21. Jun 25
    2020

    Babson Diagnostics Receives FDA Emergency Use Authorization for its SARS-CoV-2 IgG Antibody Test

    Babson announced today that its SARS-CoV-2 IgG antibody test, Babson Diagnostics aC19G1, has received emergency use authorization (EUA) from the Food and Drug Administration (FDA).

  22. May 20
    2020

    Babson Diagnostics Enters Collaborative Research Agreement with Dell Medical School to Study Immune Response to COVID-19

    Babson announced today it has entered into a collaborative research agreement with Dell Medical School at The University of Texas at Austin (Dell Med) to study the immune response to COVID-19.

  23. Apr 30
    2020

    Babson Diagnostics Launches COVID-19 Serology Test for IgG Antibodies with 100% Specificity in Austin

    Babson announces launch of its first COVID-19 serology test to detect IgG antibodies to SARS-CoV-2 in the bloodstream through a select network of retail and clinical partners in Austin, Texas.

  24. Apr 15
    2020

    Babson Diagnostics to Offer High-Throughput COVID-19 Serology Testing in Austin, Texas

    Babson announces it will launch a COVID-19 serology testing service to detect the presence of antibodies to SARS-CoV-2 in the bloodstream.

  25. Mar 11
    2020

    Babson Diagnostics Bolsters Board of Directors with Three Diagnostics Industry Experts

    Babson announces that it has expanded its board of directors to include diagnostics industry leaders David Stein (Director), Dennis Gilbert (Director), and Dave Hickey (Observer).

  26. Feb 12
    2020

    BD, Babson Diagnostics Announce Strategic Partnership Agreement to Enable Small-Volume Blood Collection for Diagnostic Testing in Retail Settings

    BD and Babson Diagnostics announce a long-term strategic partnership agreement to bring laboratory-quality, small-volume blood collection to retail pharmacies.

  27. Jul 30
    2019

    Babson Diagnostics announces its Scientific Advisory Board

    Babson has established its Scientific Advisory Board. Drs. Alan Wu, Susan A. Evans, and Robert H. Christenson will join the Babson team as scientific advisors.

  28. May 23
    2019

    Babson Diagnostics Wins Austin A-List Award

    Babson named a winner at the Greater Austin Chamber of Commerce’s 2019 Austin A-List Awards, “Austin’s premiere honor for homegrown companies.”

  29. May 14
    2019

    Babson Diagnostics welcomes Mini Kahlon to its Board of Directors

    Babson welcomes Mini Kahlon as the newest member of its Board of Directors.

  30. Mar 11
    2019

    Babson Diagnostics featured in Capital City Innovation Annual Report

    Babson featured in Capital City Innovation's 2018 Annual Review. Capital City Innovation is a 501(c)(3) nonprofit focused on cultivating collaboration and growth in Austin's Innovation District.

  31. Oct 19
    2018

    Babson Diagnostics secures $3.5 million in Series A financing from Prism Ventures

    Babson secures $3.5 million in Series A financing on October 4 from Prism Ventures, a New York-based advisory and investment firm specializing in life sciences.

Media contact

For PR and media inquiries, please reach out to pr@babsondx.com.